96700 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
PSMA-TARGETED NIR DYES AND THEIR USES
#2AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#3ANTI-FOLATE RECEPTOR CONJUGATE THERAPY FOR CANCER TREATMENT
#4Polymorph form of (r)-2-[2-amino-3-(indol-3-yl)propionylamino]-2- methylpropionic acid and uses thereof
#5AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#6INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#7PSMA-TARGETED NIR DYES AND THEIR USES
#8FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS
#9PYRROLOBENZODIAZEPINE CONJUGATES
#10Methods for the synthesis of arginine-containing peptides
#11Prodrugs of glutamine analogs
#12PSMA-targeted NIR dyes and their uses
#13NMDA ANTAGONIST PRODRUGS
#14Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#15Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide
#16N-acyldipeptide derivatives and their uses
#17Methods for the treatment of glaucoma and age-related macular degeneration by a peptide D-TRP-AIB
#18Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#19Prodrugs of glutamine analogs
#20Prodrugs of glutamine analogs
#21Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide
#22NMDA antagonist prodrugs
#23PSMA-targeted NIR dyes and their uses
#24Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
#25ANTIBIOTIC OLIGOPEPTIDE MIMETICS
#26NOVEL LIGANDS FOR PREVENTION OF NEUROTOXICITY OF THE ALZHEIMER'S DISEASE RELATED AMYLOID-BETA PEPTIDE
#27Combination of N-acyldipeptide derivatives and retinol, and methods of use thereof
#28ANTIBIOTIC OLIGOPEPTIDES
#29Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#30Prodrugs of glutamine analogs
#31Inhibitors of growth factor activation enzymes
#32NMDA antagonist prodrugs
#33Chemical synthesis and screening of bicyclic peptide libraries
#34PSMA—targeted NIR dyes and their uses
#35PSMA-targeted NIR dyes and their uses
#36Tripeptide compound, preparation method therefor, and application thereof
#37Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#38Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#39N-acyldipeptide derivatives and their uses
#40PSMA-targeted NIR dyes and their uses
#41PSMA-targeted NIR dyes and their uses
#42Methods for the treatment of glaucoma and age-related macular degeneratiion by a peptide D-TRP-AIB
#43N-terminally modified linear and branched polyamine conjugated peptidomimetics as antimicrobials agents
#44Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide
#45Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#46Chemical synthesis and screening of bicyclic peptide libraries
#47Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels
#48DENDRIMERIC PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
#49Dipeptide analogs for treating conditions associated with amyloid fibril formation
#50FPR1 antagonist derivatives and use thereof
#51ANGIOTENSIN-CONVERTING-ENZYME INHIBITING DIPEPTIDE
#52Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates
#53Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#54AGRICULTURAL PLANT-PROTECTING AGENTS CONTAINING DIPEPTIDE DERIVATIVE AS ACTIVE INGREDIENT
#55Polyconjugates for delivery of RNAi triggers to tumor cells in vivo
#56Niacin-peptide having skin whitening activity and use for same
#57Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#58Peptide nanostructures and methods of generating and using the same
#59Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#60Self assembly of naphthalene diimide derivatives and process thereof
#61Dipeptide analogs for treating conditions associated with amyloid fibril formation
#623,8-diaminotetrahydroquinoline derivative
#63Hemiasterlin derivatives and uses thereof in the treatment of cancer
#64Peptide nanostructures and methods of generating and using the same
#653,8-diaminotetrahydroquinoline derivative
#66PEPTIDE COMPOUNDS FOR DETECTING OR INHIBITING SARS CORONAVIRUS AND APPLICATION THEREOF
#67THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES
#68Inhibitors of Fibroblast Activation Protein, and Methods of Use Thereof
#69Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#70Hemiasterlin derivatives and uses thereof in the treatment of cancer
#71Peptide nanostructures and methods of generating and using the same
#72Hemiasterlin derivatives and uses thereof in the treatment of cancer
#73Method of site specific labeling of proteins and uses therefor
#74Dipeptide phenyl ethers
#75NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF
#76Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#77Peptide nanostructures and methods of generating and using the same
#78Method of reducing C-reactive protein using growth hormone secretagogues
#79Hemiasterlin derivatives and uses thereof
#80Method of site specific labeling of proteins and uses therefor
#81Dipeptide phenyl ethers
#82Inhibitors of dipeptidyl peptidase iv
#83Somatostatin antagonists and agonists that act at the sst subtype 2 receptor